Transvaginal ultrasounds may not always work for Black women
Transvaginal ultrasound, a test doctors use to check for signs of endometrial cancer, may not always give clear results for Black women.
News
-
-
Reduced lenvatinib dose for EC improves safety but lowers efficacy
Lower lenvatinib doses are often used to prevent side effects in patients with advanced EC, but this could lead to worse survival outcomes.
-
Including EC patients of all ages key to more accurate research
It is important to ensure that patients with endometrial cancer of every age category are adequately represented.
-
Physical activity may lead to better outcomes in endometrial cancer
Increased physical activity may improve survival in endometrial cancer.
-
Ibuprofen linked to reduced risk of endometrial cancer
In a recent study, women who used the most ibuprofen pills had a lower risk of endometrial cancer compared to women who used the least.
-
Potential EC therapy receives Breakthrough Therapy Designation from FDA
Rina-S is a novel therapy designed for patients with endometrial cancer who do not respond to platinum-based therapies of PD-L1 immunotherapy.
-
Laparoscopy and laparotomy result in similar outcomes in EC
There appear to be no significant outcome differences in patients with EC treated with a laparoscopic approach or laparotomy.
-
MDM2 inhibitors may make radiotherapy more effective
A new study found that combining MDM2 inhibitors with radiation killed significantly more cancer cells than either approach alone.
-
Abdominal obesity increases endometrial cancer risk in young women
Young women with repeated episodes of abdominal obesity may face a progressively higher chance of developing endometrial cancer.
-
Deep learning tech improves diagnosis of endometrial cancer
A newly developed deep learning system may improve accuracy in spotting EC during ultrasound exams.
